- Home
- » Tags
- » Hazardous drugs
Top View
- Cyclophosphamide Use CAS No
- 2012 NIOSH List of Antineoplastic and Other Hazardous Drugs
- NTP Monograph on the Systematic Review of Occupational Exposure to Cancer Chemotherapy Agents and Adverse Health Outcomes
- Occupational Exposure to Antineoplastic Agents
- When Medications Mix with Contrast Agents: the Intersection of Pharmacy and Radiology for Patient Safety and Compliance
- Federal Register/Vol. 85, No. 85/Friday, May 1, 2020/Notices
- [2014][Vyas][10197857][Phd]
- Onsite Program
- Recent Advancements in Stimuli Responsive Drug Delivery Platforms for Active and Passive Cancer Targeting
- Safe Handling of Hazardous Chemotherapy Drugs in Limited-Resource Settings
- EPA Inaction in Identifying Hazardous Waste Pharmaceuticals May Result in Unsafe Disposal
- Studies of the Origins and Control of Occupational Exposure to Cytotoxic Drugs
- Full Prescribing Information Treatment, and As Clinically Indicated
- ALIMTA Safely and Effectively
- Methotrexate in the Health Care Industry 3UhsduhgE\+Dqfkhq&Khq 'Lvhdvh3Uhyhqwlrq7Hdp 6XeplwwhgWr'U*Hrujh$Vwudnldqdnlv
- Forgotten Public Health Impacts of Cancer - an Overview Arh Hig Rada Toksikol 2017;68:287-297 287
- NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2014
- TEMODAR® (Temozolomide)
- Prescribing Information
- SAFE HANDLING of HAZARDOUS DRUGS Updated 5/22/2020
- Mitomycin (Systemic): Drug Information
- Safe Management of Wastes from Health-Care Activities
- Guide for Handling Cytotoxic Drugs and Related Waste
- Environmental Remediation of Antineoplastic Drugs: Present Status, Challenges, and Future Directions
- SPRYCEL Product Monograph
- ASHP Guidelines on Handling Hazardous Drugs
- Methotrexate/LPD/PK-04
- Methotrexate
- Draft Discussion As of 10/13/2015
- [2016]. NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016
- TEMODAR (Temozolomide) Capsules Observed Closely for the Development of Lymphopenia and PCP
- HOPA News Volume 12, Issue 1, 2015
- H:\Newsletter February 2005.Wpd
- Forgotten Public Health Impacts of Cancer – an Overview
- HIGHLIGHTS of PRESCRIBING INFORMATION These Highlights Do Not Include All the Information Needed to Use NINLARO Safely and Effec
- Chemotherapy and Other Hazardous Drugs: Safe Use Guidelines
- MUSTARGEN® (MECHLORETHAMINE Hcl for INJECTION)
- Functional Differentiation of Cytotoxic Cancer Drugs and Targeted Cancer Therapeutics ⇑ Gian C
- 2016 AAHA Oncology Guidelines for Dogs and Cats*
- Chemotherapy Revised.Pdf (New Window)
- Discovery of Selective Small-Molecule HDAC6 Inhibitor for Overcoming Proteasome Inhibitor Resistance in Multiple Myeloma
- These Highlights Do Not Include All the Information Needed to Use METHOTREXATE TABLETS Safely and Effectively
- Le Présent Fichier Est Une Publication En Ligne Reçue En Dépôt Légal, Convertie En Format PDF Et Archivée Par Bibliothèque Et Archives Nationales Du Québec
- WHO List of Priority Medical Devices for Cancer Management
- Safe Handling of Oral Antineoplastic Medications: Focus on Targeted Therapeutics in the Home Setting
- ASHP Letterhead
- Dactinomycin: Drug Information
- A Review of the Evidence for Occupational Exposure Risks To
- Safe Handling of Hazardous Drugs - Video Training Program